Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Submitted by
admin
on July 19, 2016 - 9:57am
Source:
Marketwatch
News Tags:
Arena Pharmaceuticals
FDA
obesity
Eisai
Belviq XR
Headline:
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Do Not Allow Advertisers to Use My Personal information
